“
“Material and methods. We followed 619 patients with ischemic heart disease (IHD) and

multivessel involvement of coronary arteries: 317 patients subjected to coronary artery bypass grafting (CABG, group 1) and 302 patients subjected to multivessel percutaneous coronary intervention (PCI, group 2) with implantation of drug eluting stents. Both groups had comparable clinical characteristics. During hospitalization we registered deaths and unfavorable cardiological and cerebrovascular events. In remote period after revascularization https://www.selleckchem.com/HIF.html we assessed survival, angina recurrences and related repeat revascularizations, and rate of severe cardiovascular check details complications (composite of deaths, acute myocardial infarctions [AMI], stroke, and repeat myocardial revascularizations). Results. During hospitalization there were no significant differences between groups by parameters studied: death rate was 1.7 and 0.9%, that of AMI 2.6 and 1.9%, of stroke 0.9% and 0, of composite of death, AMI, and stroke 5.1 and 1.9% (p=0.37) in groups 1 and 2, respectively. Survival in remote period was 90.2 (group 1) and 92.7% (group 2). Comparison of Kaplan-Meier survival curves also revealed no significant differences between groups. Angina recurrence/repeat

revascularization took place in 54 (17.0%) and in 64 (21.2%) patients in groups 1 and 2, respectively (p=0.128). Repeat revascularization was carried out in 32 of 54 patients (59.3%) in group 1 and in 58 Of 64 patients (90.6%) in group 2. Rate of severe unfavorable events during whole period of follow up was 33.1% in group 1 and 30.5% in group 2 (p bigger than 0.05). Conclusion. In IHD patients with multivessel coronary artery involvement and low Syntax Score

immediate and long term (5 year) results of stenting with drug eluting stents are not inferior to results of CABG.”
“Fluorescein angiography is an established technique for examining the functional integrity of the retinal microcirculation for early see more detection of changes due to retinopathy. This paper describes a new method for the registration of large Scanning Laser Ophthalmoscope sequences (SLO), where the patient has been injected with a fluorescent dye. This allows the measurement of parameters such as the arteriovenous passage time. Due to the long time needed to acquire these sequences, there will inevitably be eye movement, which must be corrected prior to the application of quantitative analysis. The algorithm described here combines mutual information-based registration and landmark-based registration.